Other languages Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange Other stock markets 18:00:00 2023-10-05 EDT			5-day change	1st Jan Change
0.175 ^CAD	+45.83%		+29.63%	-61.11%

07-05	Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
07-02	Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07-05
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07-02
Mydecine Innovations Closes Partial Debt Settlement	02-23
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02-02
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-17
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Mydecine Innovations Group Inc. Appoints John Ross as Corporate Secretary	23-07-21
Mydecine Innovations Group Appoints Todd Heinzl to the Board of Directors	23-05-29
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Mydecine Innovations Group Inc. Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting Emp Analogues	23-04-24
Mydecine Innovations Group Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
Pangenomic Health Inc. completed the acquisition of Mindleap Health Inc. from Mydecine Innovations Group Inc. (OTCPK:MYCO.F).	22-12-08
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Mydecine Innovations Group Inc. Announces Board Changes	22-08-29
Mydecine Innovations Group Inc. Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting Mdma Analogs	22-08-29
Mydecine Innovations Group Inc. Announces Board Changes	22-08-19
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Mydecine Innovations Group Inc. Announces Resignation of Directors	22-08-12
Mydecine Files Full Patent Application Covering Myco-006 Family of Novel Short-Acting Mdma Analogs	22-07-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

Other languages

Filters